96 related articles for article (PubMed ID: 25691382)
1. STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: a pilot study.
Demaret J; Dupont G; Venet F; Friggeri A; Lepape A; Rimmelé T; Morel J; Monneret G
J Leukoc Biol; 2015 Apr; 97(4):791-6. PubMed ID: 25691382
[TBL] [Abstract][Full Text] [Related]
2. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
[TBL] [Abstract][Full Text] [Related]
3. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
[TBL] [Abstract][Full Text] [Related]
4. Reduced IL-7 responsiveness defined by signal transducer and activator of transcription 5 phosphorylation in T cells may be a marker for increased risk of developing cytomegalovirus disease in patients after hematopoietic stem cell transplantation.
Pérez-Bercoff L; Vudattu NK; Byrareddy SN; Mattsson J; Maeurer M; Ljungman P
Biol Blood Marrow Transplant; 2014 Jan; 20(1):128-32. PubMed ID: 24140122
[TBL] [Abstract][Full Text] [Related]
5. IL-7 restores lymphocyte functions in septic patients.
Venet F; Foray AP; Villars-Méchin A; Malcus C; Poitevin-Later F; Lepape A; Monneret G
J Immunol; 2012 Nov; 189(10):5073-81. PubMed ID: 23053510
[TBL] [Abstract][Full Text] [Related]
6. STAT5 phosphorylation in CD4 T cells from patients with SLE is related to changes in their subsets and follow-up disease severity.
Goropevšek A; Gorenjak M; Gradišnik S; Dai K; Holc I; Hojs R; Krajnc I; Pahor A; Avčin T
J Leukoc Biol; 2017 Jun; 101(6):1405-1418. PubMed ID: 28254841
[TBL] [Abstract][Full Text] [Related]
7. Assessing IL-2-Induced STAT5 Phosphorylation in Fixed, Permeabilized Foxp3
Li C; Park JH
STAR Protoc; 2020 Dec; 1(3):100195. PubMed ID: 33377089
[TBL] [Abstract][Full Text] [Related]
8. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells.
Simonetta F; Chiali A; Cordier C; Urrutia A; Girault I; Bloquet S; Tanchot C; Bourgeois C
Eur J Immunol; 2010 Sep; 40(9):2528-38. PubMed ID: 20690182
[TBL] [Abstract][Full Text] [Related]
9. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
Adamik B; Zimecki M; Właszczyk A; Kübler A
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
[TBL] [Abstract][Full Text] [Related]
10. Increased proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells during early-stage sepsis in ICU patients.
Leng FY; Liu JL; Liu ZJ; Yin JY; Qu HP
J Microbiol Immunol Infect; 2013 Oct; 46(5):338-44. PubMed ID: 22921804
[TBL] [Abstract][Full Text] [Related]
11. Early assessment of leukocyte alterations at diagnosis of septic shock.
Venet F; Davin F; Guignant C; Larue A; Cazalis MA; Darbon R; Allombert C; Mougin B; Malcus C; Poitevin-Later F; Lepape A; Monneret G
Shock; 2010 Oct; 34(4):358-63. PubMed ID: 20220566
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract][Full Text] [Related]
13. Analysis of peripheral blood lymphocyte subsets and prognosis in patients with septic shock.
Chen X; Ye J; Ye J
Microbiol Immunol; 2011 Oct; 55(10):736-42. PubMed ID: 21831206
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.
Francois B; Jeannet R; Daix T; Walton AH; Shotwell MS; Unsinger J; Monneret G; Rimmelé T; Blood T; Morre M; Gregoire A; Mayo GA; Blood J; Durum SK; Sherwood ER; Hotchkiss RS
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515037
[TBL] [Abstract][Full Text] [Related]
15. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.
Guignant C; Lepape A; Huang X; Kherouf H; Denis L; Poitevin F; Malcus C; Chéron A; Allaouchiche B; Gueyffier F; Ayala A; Monneret G; Venet F
Crit Care; 2011; 15(2):R99. PubMed ID: 21418617
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells.
Crawley AM; Vranjkovic A; Young C; Angel JB
Eur J Immunol; 2010 May; 40(5):1396-407. PubMed ID: 20201040
[TBL] [Abstract][Full Text] [Related]
19. Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases.
Komschlies KL; Gregorio TA; Gruys ME; Back TC; Faltynek CR; Wiltrout RH
J Immunol; 1994 Jun; 152(12):5776-84. PubMed ID: 8207207
[TBL] [Abstract][Full Text] [Related]
20. [Interleukin-7, a new immunoadjuvant for the treatment of septic shock].
Monneret G; Villars-Méchin A; Demaret J; Foray AP; Venet F
Med Sci (Paris); 2014 Feb; 30(2):160-5. PubMed ID: 24572114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
